Not applicableUnknownNCT05637788What this trial is testingArtificial Intelligence and Hepatocellular CarcinomaWho this might be right forHCC Humanitas Clinical and Research Center 535
Early research (Phase 1)Study completedNCT01497444What this trial is testingSorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By SurgeryWho this might be right forKidney CancerLiver Cancer Alliance for Clinical Trials in Oncology 24
Post-approval studies (Phase 4)UnknownNCT02399033What this trial is testingXihuang Capsules Prevention of Recurrence in Patients With Hepatocellular Carcinoma After HepatectomyWho this might be right forHepatocellular Carcinoma Shuqun Cheng 1,000
Testing effectiveness (Phase 2)Study completedNCT00002608What this trial is testingCombination Chemotherapy and Tamoxifen in Treating Patients With Solid TumorsWho this might be right forAdrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more Ottawa Regional Cancer Centre 30
Not applicableStudy completedNCT00822562What this trial is testingResearch on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver CancerWho this might be right forHepatocellular Carcinoma Eastern Hepatobiliary Surgery Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00321594What this trial is testingBelinostat in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryWho this might be right forAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)UnknownNCT04888546What this trial is testingTQB2450 Combined With Anlotinib Hydrochloride in the Perioperative Treatment of Hepatocellular Carcinoma Hydrochloride Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With a High Risk of Recurrence or MetastasisWho this might be right forPatients With Resectable Hepatocellular Carcinoma Who Are at High Risk of Recurrence or Metastasi Chinese Academy of Medical Sciences 20
Not applicableStudy completedNCT00081094What this trial is testingPositron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver CancerWho this might be right forLiver Cancer Washington University School of Medicine 31
Testing effectiveness (Phase 2)Looking for participantsNCT07239245What this trial is testingStudy to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular CarcinamoWho this might be right forResectable Hepatocellular Carcinoma With High Risk of Recurrence Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Early research (Phase 1)Study completedNCT00486356What this trial is testingCapecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more University of Nebraska 46
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Not applicableStudy completedNCT02613156What this trial is testingEfficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular CarcinomaWho this might be right forRecurrent Hepatocellular Carcinoma Sun Yat-sen University 25
Testing effectiveness (Phase 2)Study completedNCT00820053What this trial is testingA Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver ResectionWho this might be right forHepatocellular Carcinoma Eastern Hepatobiliary Surgery Hospital 450
Not applicableUnknownNCT05458115What this trial is testingClinical Study of MRD Recurrence Monitoring After Surgical Resection of Hepatocellular CarcinomaWho this might be right forHCC Anhui Provincial Hospital 200
Not applicableStudy completedNCT06233708What this trial is testingAssociation Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver TransplantWho this might be right forHepatocellular Carcinoma RecurrentHepatocellular Carcinoma Asan Medical Center 2,092
Not applicableLooking for participantsNCT07839767What this trial is testingTreatment Selection by 3D Bioprinting Liver Model to Prevent Liver Cancer RecurrenceWho this might be right forHCC - Hepatocellular Carcinoma The University of Hong Kong 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07522411What this trial is testingSequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma BinYong Liang 100
Testing effectiveness (Phase 2)Study completedNCT00058487What this trial is testingEpirubicin and Thalidomide in Treating Patients With Liver CancerWho this might be right forLiver Cancer Dana-Farber Cancer Institute 12
Early research (Phase 1)UnknownNCT02719782What this trial is testingTCR-Redirected T Cell Infusion in Subject With Recurrent HBV-related HCC Post Liver TransplantationWho this might be right forRecurrent Hepatocellular Carcinoma Lion TCR Pte. Ltd. 10
Post-approval studies (Phase 4)UnknownNCT01415063What this trial is testingRadiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation Alone for Recurrent Hepatocellular CarcinomaWho this might be right forHepatocellular CarcinomaRFATACE Sun Yat-sen University 120